|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
18.70(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.25 - $2.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
5,746 |
Total Buy Value |
$0 |
$0 |
$0 |
$14,336 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
104 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Young Caroline |
|
|
2023-09-18 |
4 |
A |
$2.03 |
$112 |
D/D |
55 |
21,932 |
|
- |
|
Jones James |
|
|
2023-09-18 |
4 |
A |
$2.03 |
$112 |
D/D |
55 |
28,638 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-09-15 |
4 |
A |
$1.82 |
$42 |
D/D |
23 |
5,717,443 |
|
- |
|
Young Caroline |
|
|
2023-09-15 |
4 |
A |
$1.82 |
$42 |
D/D |
23 |
21,877 |
|
- |
|
Jones James |
|
|
2023-09-15 |
4 |
A |
$1.82 |
$42 |
D/D |
23 |
28,583 |
|
- |
|
Krogulski Kenneth |
|
|
2023-09-15 |
4 |
A |
$1.82 |
$131 |
D/D |
72 |
216,366 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-09-14 |
4 |
A |
$1.84 |
$120 |
D/D |
65 |
5,717,420 |
|
- |
|
Young Caroline |
|
|
2023-09-14 |
4 |
A |
$1.84 |
$120 |
D/D |
65 |
21,854 |
|
- |
|
Jones James |
|
|
2023-09-14 |
4 |
A |
$1.84 |
$120 |
D/D |
65 |
28,560 |
|
- |
|
Krogulski Kenneth |
|
|
2023-09-14 |
4 |
A |
$1.87 |
$608 |
D/D |
325 |
216,294 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-09-13 |
4 |
A |
$1.83 |
$119 |
D/D |
65 |
5,717,355 |
|
- |
|
Young Caroline |
|
|
2023-09-13 |
4 |
A |
$1.83 |
$119 |
D/D |
65 |
21,789 |
|
- |
|
Jones James |
|
|
2023-09-13 |
4 |
A |
$1.83 |
$119 |
D/D |
65 |
28,495 |
|
- |
|
Krogulski Kenneth |
|
|
2023-09-13 |
4 |
A |
$1.86 |
$605 |
D/D |
325 |
215,969 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-09-12 |
4 |
A |
$1.76 |
$114 |
D/D |
65 |
5,717,290 |
|
- |
|
Young Caroline |
|
|
2023-09-12 |
4 |
A |
$1.76 |
$114 |
D/D |
65 |
21,724 |
|
- |
|
Jones James |
|
|
2023-09-12 |
4 |
A |
$1.76 |
$114 |
D/D |
65 |
28,430 |
|
- |
|
Krogulski Kenneth |
|
|
2023-09-12 |
4 |
A |
$1.79 |
$582 |
D/D |
325 |
215,644 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-09-11 |
4 |
A |
$1.71 |
$111 |
D/D |
65 |
5,717,225 |
|
- |
|
Young Caroline |
|
|
2023-09-11 |
4 |
A |
$1.71 |
$111 |
D/D |
65 |
21,659 |
|
- |
|
Jones James |
|
|
2023-09-11 |
4 |
A |
$1.72 |
$112 |
D/D |
65 |
28,365 |
|
- |
|
Krogulski Kenneth |
|
|
2023-09-11 |
4 |
A |
$1.74 |
$566 |
D/D |
325 |
215,319 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-09-08 |
4 |
A |
$1.68 |
$109 |
D/D |
65 |
5,717,160 |
|
- |
|
Young Caroline |
|
|
2023-09-08 |
4 |
A |
$1.68 |
$109 |
D/D |
65 |
21,594 |
|
- |
|
Jones James |
|
|
2023-09-08 |
4 |
A |
$1.68 |
$109 |
D/D |
65 |
28,300 |
|
- |
|
2379 Records found
|
|
Page 9 of 96 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|